There are currently 2 active clinical trials seeking participants for Primary Sclerosing Cholangitis research studies. The states with the highest number of trials for Primary Sclerosing Cholangitis participants are .
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)
Recruiting
The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Gender:
ALL
Ages:
12 years and above
Trial Updated:
08/19/2025
Locations: Southern California Research Center, Coronado, California +102 locations
Conditions: Primary Sclerosing Cholangitis
FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
Recruiting
FARGO is a randomised, phase IIa, multi-centre, placebo-controlled trial to compare Faecal Microbiota Transplant (FMT) with placebo in patients with primary sclerosing cholangitis (PSC) and concomitant inflammatory bowel disease.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/25/2025
Locations: Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set +4 locations
Conditions: Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases